Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.

The American journal of surgical pathology - 1 Jan 2021

Zyla Roman E, Olkhov-Mitsel Ekaterina, Amemiya Yutaka, Bassiouny Dina, Seth Arun, Djordjevic Bojana, Nofech-Mozes Sharon, Parra-Herran Carlos

Abstract excerpt

CTNNB1 mutations and aberrant β-catenin expression have adverse prognosis in endometrial endometrioid carcinoma, and recent evidence suggests a prognostic role of β-catenin in ovarian endometrioid carcinoma. Thus, we aimed to determine the prognostic value of the CTNNB1 mutational status, and its correlation with β-catenin expression, in a well-annotated cohort of 51 ovarian endometrioid carcinomas. We performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to beta Catenin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoma, Endometrioid

Share to Disease-Free Survival

Share to Ovarian Neoplasms

Share to Prognosis

Share to Treatment Outcome

Source

Identifiers

PMID: 32769429
DOI: 10.1097/PAS.0000000000001553

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.PMID 32769429Read ↗

Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid CarcinomaSemantic proximity Read ↗

Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.Semantic proximity Read ↗

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.Semantic proximity Read ↗

Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.Semantic proximity Read ↗

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcomeSemantic proximity Read ↗

Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma.Semantic proximity Read ↗

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.Semantic proximity Read ↗

Mechanisms of mutant β-catenin in endometrial cancer progressionSemantic proximity Read ↗

Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial CancerSemantic proximity Read ↗

Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.Semantic proximity Read ↗

An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma.Semantic proximity Read ↗

Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.